Scientific Name: Atenolol
Brand Name: Tenoretic, Tenormin
Company Owner: Astrazeneca pharmaceuticals lp, Able laboratories inc, Apothecon sub bristol myers squibb co, Aurobindo pharma ltd, Caraco pharmaceutical laboratories ltd, Dava pharmaceuticals inc, Genpharm pharmaceuticals inc, Ipca laboratories ltd, Ipr pharmaceuticals inc, Mutual pharmaceutical co inc, Mylan pharmaceuticals inc, Northstar healthcare holdings ltd, Nostrum laboratories inc, Pliva inc, Sandoz inc, Scs pharmaceuticals, Teva pharmaceuticals usa inc, Teva pharmaceuticals usa, Unique pharmaceutical laboratories, Watson laboratories inc, Zydus pharmaceuticals usa inc, Astrazeneca lp
Mechanism Of Action Atenolol is a cardioselective beta-blocker, called such because it selectively binds to the β1-adrenergic receptor as an antagonist up to a reported 26 fold more than β2 receptors.
Description of the Drug: Atenolol is a synthetic beta-1 selective blocker used in the management of hypertension and chronic angina, and to reduce mortality in known or suspected myocardial infarction in hemodynamically stable patients.
Protein Data Bank: Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00335